2018
Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma
Huntington SF, Hoag JR, Zhu W, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ. Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma. Cancer 2018, 124: 4211-4220. PMID: 30216436, PMCID: PMC6263848, DOI: 10.1002/cncr.31688.Peer-Reviewed Original ResearchConceptsDiffuse large B-cell lymphomaLarge B-cell lymphomaB-cell lymphomaOlder adultsCell lymphomaPopulation-based cohort analysisHigh-quality cancer careAnthracycline-containing regimenGuideline-adherent therapyHigh-volume providersNumber of patientsLook-back periodCytotoxic regimensSystemic therapyImproved survivalClinical outcomesReduced hospitalizationsLymphoma patientsCancer careCohort analysisMedicare beneficiariesComplex surgeryDLBCL casesLymphomaClinical volume
2014
Hepatocellular carcinoma: systemic therapies and future perspectives
Mikhail S, Cosgrove D, Zeidan A. Hepatocellular carcinoma: systemic therapies and future perspectives. Expert Review Of Anticancer Therapy 2014, 14: 1205-1218. PMID: 25199765, DOI: 10.1586/14737140.2014.949246.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsHepatitis C virus infectionC virus infectionIncidence of HCCMedian survival timeCommon primary malignancyCancer-related deathCommon solid cancersFuture therapeutic directionsUnresectable diseaseLiver transplantationLocoregional therapyPrimary malignancySurgical resectionSystemic therapyTreatment optionsSystemic optionsVirus infectionHepatocellular carcinomaSolid cancersSurvival timeMolecular pathogenesisTherapeutic directionsTherapyHCCPatients